烟台市首席技师选拔管理办法
山东省烟台市人事局
烟台市首席技师选拔管理办法
第一章 总 则
第一条 为树立和落实科学人才观，实施人才强市战略，加快我市高技能人才队伍建设，提高技能人才的整体素质和社会地位，创造技能人才成长的良好社会环境，调动广大技能劳动者学技术、比贡献的积极性，更好地为建设现代制造业强市、加快我市经济社会发展服务,根据《山东省首席技师选拔管理办法》（鲁政办发〔2004〕107号），结合我市实际，制定本办法。
第二条 本办法所称烟台市首席技师，是指工人队伍中具有高超技能水平、良好职业道德、丰富实践经验，在全市本行业、领域中贡献比较突出、影响带动作用大、得到业内广泛认可的高技能人才。
第三条 烟台市首席技师选拔管理坚持以下原则：
（一）服务于经济建设和社会发展的原则；
（二）鼓励技术创新，有利于人才脱颖而出的原则；
（三）突出实绩，重在贡献的原则；
（四）公开、平等、竞争、择优的原则。
第四条 烟台市首席技师每两年选拔一次，每次30人左右，管理期限为4年。
第五条 烟台市首席技师选拔管理工作由市人才及知识分子工作领导小组统一领导，市人才及知识分子工作领导小组办公室协调市劳动和社会保障局、人事局、经贸委、外经贸局、国资委、总工会等部门组成烟台市首席技师选拔管理工作办公室，负责具体实施工作，办公室设在市劳动和社会保障局。
第二章 选拔范围和条件
第六条 烟台市首席技师选拔范围是我市各级各类所有制经济、社会组织中，具有技师（国家职业资格二级）以上职业资格、在一线岗位上直接从事技能工作的人员，优先从“烟台市有突出贡献的技师”、“烟台市技术能手”中选拔。同时，充分考虑技术技能型、知识技能型、复合技能型高技能人才的不同特点和行业分布，突出支柱产业和优势产业。
第七条 烟台市首席技师必须拥护党的路线方针政策，热爱祖国，坚持四项基本原则，遵纪守法，爱岗敬业，具有良好的职业道德，为所在单位和社会做出了重大贡献，在同行中享有很高声誉，并符合下列条件之一：
（一）个人职业技能在省内同行业中处于领先水平、市内同行业中处于拔尖水平，属全市同行业技术权威。
（二）近四年获得“中华技能大奖”、“全国技术能手”、市级以上“有突出贡献的技师”或“技术能手”等称号；或者为全国一类技能竞赛前九名成绩获得者，全国二类、省级一类技能竞赛前六名成绩获得者，省级二类、市级一类技能竞赛前三名成绩获得者，市级二类技能竞赛第一名成绩获得者。
（三）具有丰富的生产实践经验，在生产实践中创造性地解决了本行业、本工种关键性的操作技术和生产工艺难题，推动生产水平、产品质量和经济效益大幅度提高。
（四）在技术上有重大发明创造或重大技术革新，并取得重大经济效益和社会效益，获得省以上技术发明一等奖前四位、二等奖前三位的人员；获得市级技术发明一等奖前两位的人员；取得一项发明专利或两项实用新型专利并已开发应用的第一发明人。
（五）技艺高超，是某个领域的技术群体带头人，具有组织相近专业的技师进行技术攻关的能力。
（六）刻苦钻研技术，诚心传授技艺，在培训和带动技术工人队伍发展上取得显著成绩。
（七）其他有突出技术特长、重大工作成果，为经济发展做出重大贡献的技能人才。
第三章 选拔方法和程序
第八条 烟台市首席技师的选拔，采用自下而上、逐级推荐的办法产生。具体程序是：
（一）推荐申报。首席技师人选主要由所在单位推荐，也可由个人自荐或群众举荐，按要求填写《烟台市首席技师申报表》，并提供有关材料。县市区属企事业单位及其他社会组织或个人报县市区劳动保障部门；市属企事业单位，中央、省属及外地驻烟单位和其他社会组织报市劳动保障部门。
（二）初审。市、县两级劳动保障部门对申报人员进行审查、把关，提出推荐人选名单，连同有关材料一并报烟台市首席技师选拔管理办公室。
（三）审查筛选。由烟台市首席技师选拔管理工作办公室对推荐人选的有关情况进行审核，按1：3的比例筛选产生首席技师参评人选。
（四）综合评审。烟台市首席技师选拔管理工作办公室组织有关方面专家成立烟台市首席技师评审委员会，对首席技师参评人选进行综合评审，并组织进行现场技能考查，提出人选名单，报市人才及知识分子工作领导小组审定。
（五）社会公示。对首席技师人选，通过新闻媒体向社会公示，并在其所在单位张榜公示，广泛听取各方面的意见、建议。
（六）命名表彰。市人才及知识分子工作领导小组研究确定烟台市首席技师名单，报市政府命名、颁发证书，进行表彰。
第四章 使用和待遇
第九条 充分发挥烟台市首席技师在企业及公共建设领域生产、管理和技术创新中的积极作用。
（一）市劳动和社会保障局组织首席技师承担技术革新、技术攻关任务，推广新技术、新工艺和先进操作法，承担“名师带徒”，进行人才培养。
（二）在不同行业选择建立“烟台市首席技师工作站”，组织烟台市首席技师承担社会服务任务，参与重大生产建设项目咨询，重大技术联合攻关，开展同行业技能交流，绝招、绝技展示等活动。
（三）有关部门和所在单位要积极创造条件，有计划地安排烟台市首席技师脱产学习、参观考察和技术交流。
（四）烟台市首席技师在进行项目研发、技术革新、成果转化时，有关部门和所在单位要优先予以经费和其他方面的支持。
第十条 烟台市首席技师在管理期间，每人每月发给市政府津贴600元。符合山东省首席技师选拔条件的，推荐申报山东省首席技师。享受山东省首席技师津贴的，不再享受烟台市首席技师津贴；享受烟台市首席技师津贴的，不再享受其他市级政府津贴。
第十一条 所在单位对烟台市首席技师可以参照企业经营者实行年薪制。首席技师技术成果转化所得收益，应按照一定比例分配给个人。
第十二条 市里每年组织对高层次人才进行健康查体时，安排烟台市首席技师参加。所在单位每年为烟台市首席技师安排15天的带薪休假。
第十三条 烟台市首席技师在管理期内，因工作需要，经有关部门批准，可暂不办理退休手续。
第五章 管 理
第十四条 烟台市首席技师名单纳入烟台市高层次人才库，进行重点管理。
第十五条 由市劳动和社会保障局建立烟台市首席技师档案，对烟台市首席技师实行年度考核评估制度。
第十六条 凡属下列情况之一的，取消其称号，停止相应待遇：
（一）不再从事技能或技术岗位工作的；
（二）连续两年考核不合格的；
（三）未经组织同意出市逾期不归的，或调往市外工作的；
（四）弄虚作假，谎报成果，采取不正当手段骗取本称号的；
（五）因个人过失给国家、集体、他人造成重大损失和严重后果的；
（六）被追究刑事责任的；
（七）其他原因不宜再作为首席技师管理的。
第十七条 管理期满后，符合条件的可继续参与选拔。
第六章 附 则
第十八条 各县市区及企事业单位可根据本办法制定本地本单位的首席技师选拔管理制度。
第十九条 本办法自发布之日起施行。
Provisions for Drug Advertisement Examination
State Food and Drug Administration，State Administration for Industry and Commerceof the People’s Republic of China
Provisions for Drug Advertisement Examination
(SFDA Decree No. 27)
The Provisions for Drug Advertisement Examination, adopted by the State Food and Drug Administration and the State Administration for Industry and Commerce of the People’s Republic of China, is now issued in the decree sequence number of the State Food and Drug Administration. The Provisions shall go into effect as of the date of May 1, 2007.
Shao Mingli
Commissioner
State Food and Drug Administration
Zhou Bohua
Minister
State Administration for Industry and Commerceof the People’s Republic of China
March 13, 2007
Provisions for Drug Advertisement Examination
Article 1 The Provisions are formulated for the purposes of strengthening regulation on drug advertisements and ensuring the authenticity and legality of drug advertisements in accordance with the Advertisement Law of the People’s Republic of China (hereinafter referred to as Advertisement Law), the Drug Administration Law of the People's Republic of China (hereinafter referred to as Drug Administration Law), the Regulations for the Implementation of Drug Administration Law of the People's Republic of China (hereinafter referred to as Regulations for the Implementation of Drug Administration Law) and other regulations related to supervision on advertisements and drugs.
Article 2 A drug advertisement refers to any advertisement published through various media or forms containing drug name, indications (functions) or other relevant contents, and shall be examined and approved in accordance with the Provisions.
Where only the names of non-prescription drugs (including adopted names and trade names) are publicized or only the names of prescription drugs (including adopted names and trade names) are publicized in professional medical or pharmaceutical journals, the examination is not required.
Article 3 The drug advertisement applied for examination shall be approved provided that it conforms to the following laws, regulations and related provisions:
(1) Advertisement Law;
(2) Drug Administration Law;
(3) Regulations for Implementation of Drug Administration Law;
(4) Criteria for Examining and Publishing Drug Advertisement;
(5) Other provisions of the State on advertisement regulation.
Article 4 The drug regulatory departments of the provinces, autonomous regions or municipalities directly under the Central Government are the drug advertisement examination authorities responsible for examining drug advertisements within their administrative regions. The administrative departments for industry and commerce at or above the county level are supervision and control authorities for drug advertisements.
Article 5 The State Food and Drug Administration shall guide and supervise the examination conducted by drug advertisement examination authorities and punish, in accordance with law, the examination authorities that have violated the Provisions.
Article 6 An applicant for a drug advertisement approval number must be an eligible drug manufacturer or distributor. Where the applicant is a drug distributor, the consent of the drug manufacturer is required.
An applicant may entrust an agent with the application for a drug advertisement approval number.
Article 7 An application for a drug advertisement approval number shall be submitted to the drug advertisement examination authority in the place where the drug manufacturer is located.
An application for an import drug advertisement approval number shall be submitted to the drug advertisement examination authority in the place where the agent of the import drug is located.
Article 8 Where a drug manufacturer or distributor applies for a drug advertisement approval number, it shall submit an Application Form for Drug Advertisement (Appendix 1) with sample manuscript (sample film or sample record) of which the content is consistent with that to be published attached, and an electronic document of drug advertisement application. It shall also submit the following proof documents that are authentic, legal and valid:
(1) Copy of the Business License of the applicant;
(2) Copy of the Drug Manufacturing Certificate or the Drug Supply Certificate of the applicant;
(3) Where the applicant is a drug distributor, the original document proving that the drug manufacturer authorizes the drug distributor to be the applicant shall be submitted;
(4) Where an agent submits an application for a drug advertisement approval number on behalf of the applicant, an original authorization letter given by the applicant to the agent, a copy of business license of the agent and other documents proving the subject’s qualifications shall be submitted;
(5) Copies of the drug approval document (including Import Drug License or Pharmaceutical Product License), copy of approved insert sheet, and label and insert sheet used in practice;
(6) For non-prescription drug advertisement, a copy of registration certificate of non-prescription drug examination or copies of relevant certificates is required;
(7) Where an applicant applies for an import drug advertisement approval number, copies of qualification certificates of the agent of the import drug shall be submitted;
(8) Where the trade name, registered trademark and patent of the drug are involved in an advertisement, copies of the valid certificates and other relevant documents proving the authenticity of the advertisement shall be submitted.
The copy of any approval document prescribed in this Article shall be sealed by the document holder.
Article 9 An advertisement application by an enterprise for a drug shall not be accepted by the drug advertisement examination authorities under any of the following circumstances:
(1) Any of the circumstances under which the application shall be rejected as prescribed in Article 20, Article 22 and Article 23 of the Provisions;
(2) An administrative procedure to withdraw a drug advertisement approval number is in process.
Article 10 After receiving an application for drug advertisement approval number, where the dossier is complete and in conformity with statutory requirements, the drug advertisement examination authority shall issue an Acceptance Notice of Drug Advertisement; where the dossier is incomplete or not conforming to the statutory requirements, one notification on all the content to be supplemented or corrected shall be given to the applicant on the spot or within five working days; if the notification to the applicant is not issued within the timeline, the application is deemed as being accepted upon the date when the dossier is received.
Article 11 Within ten working days upon accepting an application, the drug advertisement examination authority shall check the authenticity, legality and validity of the documents submitted by the applicant, and shall examine the advertisement content in accordance with law. For the drug advertisement in conformity with statutory requirements, a drug advertisement approval number shall be issued; for those not in conformity with statutory requirements, the authority shall make a decision of not issuing a drug advertisement approval number and notify the applicant of the decision with reasons in written form and the applicant’s right to apply for administrative reconsideration or to bring an administrative suit by law.
For approved drug advertisement, the drug advertisement examination authority shall report to the State Food and Drug Administration for records and send the approved Application Form for Drug Advertisement to the authority responsible for advertisement supervision and control at the same level for records. Where there is any problem in the drug advertisement reported to the State Food and Drug Administration for records, the State Food and Drug Administration shall instruct the drug advertisement examination authority to correct it.
The drug regulatory departments shall announce the approved drug advertisement timely.
Article 12 Where a drug advertisement is to be published in the province, autonomous region or municipality directly under the Central Government other than the place where the drug manufacturer and the agent of the import drug are located (hereinafter referred to as “non-local drug advertisement”), it shall, before being published, be submitted for records to the drug advertisement examination authority in the place where the advertisement is to be published.
Article 13 The following materials for non-local drug advertisement shall be submitted for record:
(1) Copy of the Application Form for Drug Advertisement;
(2) Copy of the approved drug insert sheet;
(3) For television or audio broadcast advertisement, it is required to submit the audio tape, compact disc or other medium carrier on which the content is consistent with the approved content.
The copy of any document prescribed in this Article shall be sealed by the document holder.
Article 14 For application for putting non-local drug advertisement on record in accordance with Articles 12 and Article 13 of the Provisions, the drug advertisement examination authority shall, within five working days after accepting the application, put such drug advertisement on record, endorse the word “recorded” on the Application Form for Drug Advertisement, affix the seal specific for drug advertisement examination and send the form to the supervision and control authorities for advertisements at the same level for future reference.
Where the drug advertisement examination authority of a place where a drug advertisement is to be put on record finds that the drug advertisement is not conformed with the relevant provisions, it shall fill in the Opinion on the Record of Drug Advertisement Examination (Appendix 2), submit it to the original drug advertisement examination authority for check, and copy it to the State Food and Drug Administration.
Within five working days upon receiving the Opinion on the Record of Drug Advertisement Examination, the original drug advertisement examination authority shall give its opinions to the drug advertisement examination authority of the place where the drug advertisement is to be put on record. Where no consensus is achieved between the original drug advertisement examination authority and the drug advertisement examination authority of the place where a drug advertisement is to be put on record, the case may be submitted to the State Food and Drug Administration that shall make a final judgment.
Article 15 The valid term of a drug advertisement approval number is one year. It shall become invalid upon expiration.
Article 16 The content of an approved drug advertisement is not allowed to be changed when being published. Where any change to the drug advertisement is needed, a new drug advertisement approval number shall be obtained.
Article 17 Where an advertisement applicant publishes a drug advertisement by itself, it shall keep the original Application Form for Drug Advertisement for two years for future check.
Where an advertisement publisher or advertising operator is authorized by the applicant to publish a drug advertisement, it shall check the original Application Form for Drug Advertisement, publish the advertisement in accordance with the approved content and keep a copy of the Applicant Form for Drug Advertisement for two years for future check.
Article 18 Where there is any of the following circumstances for an approved drug advertisement, the original drug advertisement examination authority shall issue a Notice of Drug Advertisement Re-examination (Appendix 3) and conduct the re-examination. The drug advertisement may continue to be published during the re-examination.
(1) The State Food and Drug Administration finds that the content of the drug advertisement approved by the drug advertisement examination authority is not in conformity with the provisions;
(2) A supervision and control authority for advertisement at or above provincial level makes a re-examination proposal;
(3) Other circumstances where a re-examination is required by a drug advertisement examination authority.
After re-examination, where the drug advertisement is not in conformity to the statutory requirements, the Application Form for Drug Advertisement shall be taken back and the original drug advertisement approval number shall become invalid.
Article 19 Drug advertisement examination authorities shall cancel the drug advertisement approval number in any of the following circumstances:
(1) Where a Drug Manufacturing Certificate or the Drug Supply Certificate is revoked;
(2) Where a drug approval document is withdrawn or cancelled;
(3) Where the State Food and Drug Administration or the drug regulatory department of the province, autonomous region or municipality directly under the Central Government instructs to stop the production, sales and use of the drug.
Article 20 For any alteration to the approved content of a drug advertisement for false propaganda, the drug regulatory departments shall instruct to stop the publication of the advertisement immediately, revoke the drug advertisement approval number, and shall not accept any application for advertisement of the drug within one year.
Article 21 Where any illegal advertisement in which the scope of indications (functions) of the drug is expanded without authorization, the therapeutic effectiveness is exaggerated extremely, or which seriously cheats or misleads the customers, is found, the drug regulatory department at or above the provincial level shall take mandatory administrative measures to suspend the sales of the drug within their administrative area and order the enterprise that illegally publishes the drug advertisement to issue a correction notice in relevant local media.
After the enterprise that illegally publishes the drug advertisement issues a correction notice as required, the drug regulatory department at or above the provincial level shall make a decision on lifting the mandatory administrative measures within 15 working days; where it is necessary to test the drug, the drug regulatory departments shall determine whether to lift the mandatory administrative measures within 15 days as from the day when the test report is issued.
Article 22 Where a drug advertisement application providing false materials is found by the drug advertisement examination authority during the examination, no further application of the enterprise in respect of the advertisement of the drug shall be accepted within one year.
Article 23 Where a drug advertisement with an approval number is found by the drug advertisement examination authority to have provided false materials, such drug advertisement approval number shall be revoked and no further application from the enterprise in respect of the advertisement of the drug shall be accepted within three years.
Article 24 Any drug advertisement, of which the approval number is taken back, cancelled or revoked in accordance with Article 18, Article 19, Article 20 and Article 23 of the Provisions, shall be discontinued for publication immediately; non-local drug advertisement examination authorities shall stop filing the record of the advertisement of the enterprise with the drug advertisement approval number.
Where a drug advertisement examination authority takes back, cancels or withdraws a drug advertisement approval number in accordance with Article 18, Article 19, Article 20 and Article 23 of the Provisions, it shall notify the supervision and control authority for advertisements at the same level within five working days from the day when the administrative decision on the matter is made; the supervision and control authority for advertisements shall handle it in accordance with law.
Article 25 Where a non-local drug advertisement is found not put on record in the drug advertisement examination authority of the place where it is published, the authority shall instruct to file its record within a time limit. If the record is not filed within the time limit, the drug advertisement in the above-mentioned place shall be suspended.
Article 26 The drug regulatory department at or above the county level shall monitor and check the publishing of drug advertisement that has been examined and approved. For any illegal drug advertisements, drug regulatory departments at all levels shall fill in the Notice on the Transfer of Illegal Drug Advertisement (Appendix 4) and transfer it to an supervision and control authority for advertisements at the same level together with such materials as samples of illegal drug advertisement; where the content of approved non-local drug advertisement is altered without permission, the drug advertisement examination authority of the place where the advertisement is published shall advise the original drug advertisement examination authority to revoke its approval number in accordance with Article 92 of the Drug Administration Law and Article 20 of the Provisions.
Article 27 Where an illegal drug advertisement is published and the circumstances are serious, the drug regulatory department of province, autonomous region or municipality directly under the Central Government shall announce the matter to the public and timely report it to the State Food and Drug Administration. The State Food and Drug Administration shall summarize and release the collected information periodically.
Where any false or illegal drug advertisement is published and the circumstances are serious, it shall be announced to the public jointly by the State Administration for Industry and Commerce and the State Food and Drug Administration if necessary.
Article 28 For any drug advertisement published without approval, or the contents published inconsistent with the approved ones, the supervision and control authority for advertisements shall impose a punishment in accordance with Article 43 of the Advertisement Law; where it constitutes false advertisement or misleading propaganda, the supervision and control authorities for advertisements shall impose a punishment in accordance with Article 37 of the Advertisement Law and Article 24 of Anti-Unfair Competitions Law.
In the process of investigation of an illegal drug advertisement, where there is a need to affirm any drug technical information, the supervision and control authority for advertisements shall notify the drug regulatory department at or above the provincial level. The drug regulatory department at or above the provincial level shall give the affirmation result to the supervision and control authorities for advertisements within ten working days after receiving the notification.
Article 29 The staff members that examine and supervise drug advertisements shall be trained in such laws and regulations as the Advertisement Law and the Drug Administration Law. Where the staff members in drug advertisement examination department or in supervision and control authority for drug advertisements neglect their duty, abuse their power, or practice favoritism and commit irregularities, they shall be given an administrative sanction in accordance with law. If a crime is constituted, they shall be investigated for their criminal liabilities in accordance with law.
Article 30 A drug advertisement approval number shall be “X Yao Guang Shen (Shi) No. 0000000000", “X Yao Guang Shen (Sheng) No. 0000000000", “X Yao Guang Shen (Wen) No. 0000000000". “X” is the abbreviation for a province, autonomous region or municipality directly under the Central Government. “0000000000” is a number with ten digits, in which the first six represent year and month of the examination, and the last four represent advertisement approval sequence number. “Shi”, “Sheng” or “Wen” represents certain classification code used in advertising media.
Article 31 These Provisions shall come into force as of May 1, 2007. The Provisions for Drug Advertisement Examination issued by the State Administration for Industry and Commerce and the Ministry of Health (Decree of State Administration for Industry and Commerce No. 25) on March 22, 1995 shall be annulled therefrom.
